The long term objectives of this project are to induce functional regeneration in the adult nervous system. To this end, we are conducting experiments in the well-defined fimbria-fornix (FF) lesion model and in an analogous model using lesions to the perforant path (PP). The FF model has been used to demonstrate the effectiveness of NGF administration to spare lesioned septal neurons and promote their regeneration. Specifically, using the FF model we plan to: 1) Determine if neurotrophic factors other than NGF enhance neuronal survival and regeneration from the lesioned septum and what other neuronal phenotypes are responsive. 2) Determine whether and which specific surface molecules may be located on regenerating axons or substrate cells that are involved in elongation and guidance in regeneration. 3) Determine if providing additional trophic/tropic factors can enhance target innervation and functional recovery.
The specific aims of the PP model experiments are to: 1) Prevent death and degeneration of entorhinal layer II neurons by administration of trophic factors. 2) Induce regeneration of entorhinal fibers across the trophic bridging graft.
These aims will be accomplished by placing collagen-plug bridging grafts containing fibroblasts genetically engineered to produce NGF, NT3, beta-FGF, BDNF, SDGF, or beta-Gal into the lesion cavities. Sections will be assessed by brightfield or multiple-fluorescent immunolabeling using confocal microscopy to determine responsive neuronal phenotypes and extent of regeneration. Quantitation of neuronal number in the septum or entorhinal cortex will be made using unbiased stereology and assessment of fiber density through the graft by computer-assisted optical density measurements. Surface molecules will be investigated using confocal microscopy of identified antibodies against tenascin, laminin, astrotactin, NILE, N-cadherin, and N-CAM. Specificity of innervation will be assessed using electron microscopy. A battery of behavioral tests will be used to determine if and which of the specific neuronal systems regenerated and result in functional recovery. By extending our studies from the FF model to the PP model, we will test the generality of this approach toward adult CNS regeneration.

Project Start
1998-06-01
Project End
2000-05-31
Budget Start
Budget End
Support Year
8
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Maher, Pamela (2014) Proteasome Assay in Cell Lysates. Bio Protoc 4:
Brennand, K J; Simone, A; Tran, N et al. (2012) Modeling psychiatric disorders at the cellular and network levels. Mol Psychiatry 17:1239-53
Brennand, Kristen J; Simone, Anthony; Jou, Jessica et al. (2011) Modelling schizophrenia using human induced pluripotent stem cells. Nature 473:221-5
Brennand, Kristen J; Gage, Fred H (2011) Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia. Stem Cells 29:1915-22
Maher, Pamela (2008) Proteasome inhibitors prevent oxidative stress-induced nerve cell death by a novel mechanism. Biochem Pharmacol 75:1994-2006
Maher, Pamela (2008) The flavonoid fisetin promotes nerve cell survival from trophic factor withdrawal by enhancement of proteasome activity. Arch Biochem Biophys 476:139-44
Maher, Pamela; Salgado, Karmen F; Zivin, Justin A et al. (2007) A novel approach to screening for new neuroprotective compounds for the treatment of stroke. Brain Res 1173:117-25
Shackelford, Deborah A; Yeh, Richard Y (2006) Modulation of ERK and JNK activity by transient forebrain ischemia in rats. J Neurosci Res 83:476-88
Shackelford, Deborah A (2006) DNA end joining activity is reduced in Alzheimer's disease. Neurobiol Aging 27:596-605
Lapchak, Paul A (2006) Memantine, an uncompetitive low affinity NMDA open-channel antagonist improves clinical rating scores in a multiple infarct embolic stroke model in rabbits. Brain Res 1088:141-7

Showing the most recent 10 out of 142 publications